Skip to main content

Table 2 Health Characteristics of a US adult population by Fibromyalgia (FMS) status, Adjusted for Demographic and Lifestyle factors, C8 Health Project, 2005–2006

From: Potential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey

Characteristic

Total Population

FMS

Non-FMS

Adjusted Odds Ratioa

 

N (%) / Mean (SD)

OR (CI), p-value

BMI+

28.53 (6.31)

30.47 (7.22)

28.49 (6.28)

1.02 (1.01–1.03), .001*

 ≤ 24.99 (ref)

16,258 (31.0%)

279 (24.8%)

15,979 (31.1%)

−

 25.5–29.99

18,200 (34.6%)

320 (28.4%)

17,880 (34.8%)

1.11 (.932–1.31), .248

 30–34.9

10,704 (20.4%)

251 (22.3%)

10,453 (20.3%)

1.24 (1.02–1.49), .028*

 35+

7373 (14.0%)

275 (24.4%)

7098 (13.8%)

1.43 (1.18–1.74), .0003*

Number of Comorbidities

1.29 (1.27)

2.78 (1.59)

1.25 (1.24)

1.60 (1.54–1.67), <.0001*

Comorbidity Index

 None (ref)

16,778 (31.9%)

58 (5.2%)

16,720 (32.5%)

−

 1

16,999 (32.4%)

177 (15.7%)

16,822 (32.7%)

2.38 (1.77–3.21), <.0001*

 2

10,535 (20.1%)

301 (26.8%)

10,234 (19.9%)

5.16 (3.88–6.86), <.0001*

 3+

8223 (15.7%)

589 (52.4%)

7634 (14.9%)

10.46 (7.90–13.84), <.0001*

Autoimmune disorder

2192 (4.2%)

220 (19.6%)

1972 (3.8%)

3.43 (2.89–4.06), <.0001*

Osteoarthritis

4093 (7.7%)

411 (35.5%)

3782 (7.1%)

3.86 (3.34–4.45), <.0001*

Allergies or Chronic Sinusitis

24,470 (46.6%)

893 (79.4%)

23,577 (45.9%)

2.91 (2.51–3.38), <.0001*

Kidney disorder

5202 (9.9%)

226 (20.1%)

4976 (9.7%)

1.72 (1.47–2.01), <.0001*

Respiratory disease

7385 (14.1%)

342 (30.4%)

7043 (13.7%)

1.89 (1.64–2.17), <.0001*

Cardiovascular disease

4661 (8.9%)

148 (13.2%)

4513 (8.9%)

1.25 (1.03–1.51), .027*

Liver disease

684 (1.3%)

38 (3.4%)

646 (1.3%)

1.51 (1.06–2.16), .022*

Endocrine Disorder

4083 (7.8%)

264 (23.5%)

3819 (7.4%)

1.82 (1.57–2.12), <.0001*

Diabetes

4778 (9.1%)

157 (14.0%)

4621 (9.0%)

.978 (.813–1.18), .810

Frequent Headache

10,105 (19.2%)

439 (39.0%)

9666 (18.8%)

2.03 (1.78–2.31), <.0001*

Sleep Impairment Scoreb

4.00 (3.56)

7.32 (3.29)

3.93 (3.53)

1.23 (1.21–1.25), <.0001*

Mood Disturbance Scorem

4.59 (3.70)

7.25 (3.40)

4.53 (3.68)

1.19 (1.17–1.21), <.0001*

  1. Note: Column Percentages shown
  2. *Significant at p < 0.05
  3. aModel adjusted for demographic covariates Age, Gender, Marital Status, Employment, Education level, White Race, and Household Income; Also adjusted for lifestyle covariates Tobacco Use and Current Alcohol consumption
  4. bSleep impairment derived from responses to four individual questions regarding the frequency of short sleep, fitful sleep, insomnia and/or daytime somnolence; higher score indicates increased frequency of impairment
  5. mMood disturbance derived from responses to four individual questions regarding frequent mood swings, irritability, fatigue and/or inability to concentrate; higher score indicates increased frequency of disturbance
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us